Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc

NEW
NAS:REGN (USA)   Ordinary Shares
$ 602.64 +2.88 (+0.48%) 11:08 PM EST
15.74
P/B:
2.25
Market Cap:
$ 65.88B
Enterprise V:
$ 59.26B
Volume:
864.91K
Avg Vol (2M):
1.03M
Warning! GuruFocus detected 3 Severe warning signs with REGN. Try a 7-Day Free Trial to check it out.
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
864.91K
Market Cap $:
65.88B
15.74
Avg Vol (2M):
1.03M
Enterprise Value $:
59.26B
PB Ratio:
2.25
Website SEC Filings Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢
Market Cap $ M 65,883.43
Enterprise Value $ M 59,260.47
P/E(ttm) 15.74
PE Ratio without NRI 13.80
Forward PE Ratio 15.07
Price/Book 2.25
Price/Sales 4.86
Price/Free Cash Flow 19.62
Price/Owner Earnings 24.92
Payout Ratio % --
Revenue (TTM) $ M 14,202.00
EPS (TTM) $ 38.28
Beneish M-Score -2.25
10-y EBITDA Growth Rate % 21.70
5-y EBITDA Growth Rate % 9.70
y-y EBITDA Growth Rate % 11.90
EV-to-EBIT 12.26
EV-to-EBITDA 11.14
PEG 1.42
Shares Outstanding M 109.32
Net Margin (%) 31.07
Operating Margin % 28.81
Pre-tax Margin (%) 33.66
Quick Ratio 3.95
Current Ratio 4.73
ROA % (ttm) 12.34
ROE % (ttm) 15.78
ROIC % (ttm) 16.65
Dividend Yield % 0.15
Altman Z-Score 7.12
Piotroski F-Score 5.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y Y
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

REGN Number of Guru Trades

To

REGN Volume of Guru Trades

To

Gurus Latest Trades with NAS:REGN

No Available Data

NAS:REGN is held by these investors

Guru
Portfolio Date
Current Shares
% of Shares outstanding
% of Total Assets Managed
Comment
Dodge & Cox 2024-12-31
2,321,316
2.120
0.96%
Add 0.41%
Vanguard Health Care Fund 2024-09-30
249,894
0.230
0.55%
Reduce -63.01%
Jefferies Group 2024-12-31
35,822
0.030
0.16%
Add 30.29%
Joel Greenblatt 2024-12-31
11,423
0.010
0.08%
Add 103%
Ken Fisher 2024-12-31
5,890
0.010
0%
Add 16.47%
Mario Gabelli 2024-12-31
563
0.000
0%
Add 54.25%
Total 6
  • 1

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

News about NAS:REGN

Total 0
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.